Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFranchise Brands Regulatory News (FRAN)

Share Price Information for Franchise Brands (FRAN)

Share Price is delayed by 15 minutes
Get Live Data
147.00    0.25 (0.17%)
Bid:
146.50
Ask:
148.00
Spread: 1.50 (1.024%)
Market Cap: £281.77m
FRAN Live PriceLast checked at - London Stock Exchange

Intraday Franchise Brands Share Chart

Share Premium Cancellation

Today 12:41

RNS Number : 7986H
Franchise Brands PLC
10 June 2026
Β 

10 June 2026

FRANCHISE BRANDS PLC

("Franchise Brands", the "Group" or the "Company")

Β 

Share Premium Cancellation

Franchise Brands plc (AIM: FRAN), a platform of international B2B franchise brands focused on essential services through a mobile workforce, announces that the Share Premium Cancellation has now become effective.

Following the sanction by the High Court of England and Wales (the "Court") of the reduction of capital by way of cancellation of the Company's share premium account (the "Share Premium Cancellation") on 2 June 2026, the order of the Court confirming the Share Premium Cancellation and a statement of capital approved by the Court were registered by the Registrar of Companies on 4 June 2026.

Details of the Share Premium Cancellation were set out in the Notice of General Meeting and explanatory circular dated 24 March 2026, and the Share Premium Cancellation was approved by the shareholders of the Company at a general meeting of the Company on 30 April 2026. The effect of the Share Premium Cancellation is to create approximately Β£131.1m of distributable reserves in the accounts of the Company. This will provide the flexibility to enable the following, should circumstances make them appropriate: (i) further share buybacks; (ii) the future payment by the Company of dividends to its shareholders; and (iii) other corporate purposes of the Company.

The Share Premium Cancellation does not affect the rights attached to the Ordinary Shares and there is no change in the number of Ordinary Shares in issue (or their nominal value).

​

Enquiries:

Β 

Franchise Brands plc

+ 44 (0) 1625 813231

Stephen Hemsley, Executive Chairman

Peter Molloy, Chief Executive Officer

Neil Miller, Chief Financial Officer

Julia Choudhury, Corporate Development Director

Stifel Nicolaus Europe Limited (Nominated Adviser and Joint Broker)

+44 (0) 20 7710 7600

Matthew Blawat

Jason Grossman

Β 

Allenby Capital Limited (Joint Broker)

+44 (0) 20 3328 5656

Jeremy Porter / Liz Kirchner (Corporate Finance)

Amrit Nahal / Tony Quirke (Sales & Corporate Broking)

Β 

MHP Group (Financial PR)

+44 (0) 20 3128 8100

Katie Hunt / Hugo Harris

+44 (0) 7884 494112

franchisebrands@mhpgroup.com

Β 

About Franchise Brands plc

Franchise Brands (FTSE AIM UK 50) is a platform of international B2B franchise brands focused on essential services through a mobile workforce. We have clarity of purpose which is acquire, develop and scale proven franchise businesses. Our focus is to help our franchisees grow their businesses, so that "as they grow, we grow".

Our franchise partners benefit from our One Franchise Brands platform which includes shared, bespoke technology systems, a strategic growth maximisation methodology and management franchising expertise.

We have 7 franchise brands in 10 countries, approximately 600 franchisees and 2,500 mobile service vehicles. We focus on resilient reactive and planned services and carry out approximately 1.3m jobs per year at an average value of Β£325 for approximately 65,000 commercial customers. We earn an average management service fee of 15% from each job undertaken by our franchise partners.

Our market-leading brands include Pirtek, Metro Rod and Filta. We employ approximately 600 people across the Group and there are over 3,000 people employed in the franchise community.

For further information, visitΒ www.franchisebrands.co.uk.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCBBGDLCXBDGLG
Date   Source Headline
10th Jun 202612:41 pmRNSShare Premium Cancellation
8th Jun 20264:38 pmRNSGrant of Options to director
26th May 202612:58 pmRNSGrant of Options to director
18th May 20267:00 amRNSAppointment of new CFO & Group Delivery Director
30th Apr 20264:01 pmRNSResult of General Meeting
30th Apr 20264:00 pmRNSResult of Annual General Meeting
30th Apr 20267:00 amRNSAGM Statement and Q1 Trading Update
7th Apr 202612:29 pmRNSHolding(s) in Company
31st Mar 20265:13 pmRNSProposed Share Premium cancellation
31st Mar 20265:13 pmRNSAnnual Report and Accounts & Notice of AGM
27th Mar 20267:00 amRNSGrant of Options to directors
27th Mar 20267:00 amRNSDirectors’ dealings
26th Mar 20267:00 amRNSDirectors' dealings
25th Mar 20267:00 amRNSFinal Results
18th Mar 20267:00 amRNS-RInvestor Presentation via Investor Meet Company
11th Mar 20263:13 pmRNSHolding(s) in Company
11th Mar 20263:13 pmRNSHolding(s) in Company
5th Mar 202611:17 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSNotice of Results
2nd Mar 20262:00 pmRNSHolding(s) in Company
28th Jan 20267:00 amRNSTrading Update
21st Jan 20263:00 pmRNSHolding(s) in Company
21st Jan 20262:55 pmRNSHolding(s) in Company
12th Jan 20267:00 amRNSHolding(s) in Company
12th Nov 20257:00 amRNSQ3 Trading Update
3rd Nov 20252:00 pmRNSHolding(s) in Company
16th Oct 20257:00 amRNSDirectors’ dealings
14th Oct 20257:00 amRNSEBT share purchase programme update
9th Oct 20253:48 pmRNSDirectors’ dealings – Replacement
9th Oct 20257:00 amRNSDirectors' dealings
1st Oct 20255:00 pmRNSDirectors’ dealings
29th Sep 20256:05 pmRNSDirectors’ dealings
23rd Sep 20252:00 pmRNSHolding(s) in Company
5th Aug 20258:46 amRNSUpdate on potential listing
31st Jul 20251:52 pmRNSGrant of Options to director
30th Jul 20257:00 amRNSInterim Results
21st Jul 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
7th Jul 20257:00 amRNSNotice of Interim Results
23rd Jun 20257:00 amRNS-RInclusion in FTSE AIM UK 50 Index
28th May 202511:06 amRNSHolding(s) in Company
19th May 20257:00 amRNSMove to SETS
7th May 20253:00 pmRNSResult of AGM
7th May 20257:00 amRNSAGM Statement and Q1 Trading Update
9th Apr 202510:00 amRNSDirectors' dealings
8th Apr 202510:00 amRNSDirectors' dealings
7th Apr 202510:00 amRNSDirectors’ dealings
4th Apr 20254:00 pmRNSHolding(s) in Company
2nd Apr 20259:00 amRNS-RInvestor Presentation via Investor Meet Company
1st Apr 20252:19 pmRNSAnnual Report and Accounts & Notice of AGM
31st Mar 202510:30 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.